MDXG Q1 2024 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$85M+18.2% YoY

Gross Profit

$72M84.4% margin

Operating Income

$13M15.6% margin

Net Income

$9M10.9% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

-$166,000

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$222M

Total Liabilities

$66M

Stockholders' Equity

$156M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$85M	$72M	+18.2%
Gross Profit	$72M	$59M	+20.7%
Operating Income	$13M	-$340,000	+3981.8%
Net Income	$9M	-$5M	+285.9%

Revenue Segments

Surgical

$28M100%